| 3232–TARGETING SOD1 INDUCES SYNTHETIC LETHAL KILLING OF PPM1D-MUTANT LEUKEMIA CELLS L Zhang, J Hsu, E Braekeleer, CW Chen, T Dayaram, R Murdaugh, ... Experimental Hematology 124, S165, 2023 | | 2023 |
| A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3β as a novel tumor suppressor in lung cancer B Halmos, DS Basseres, S Monti, F D ‘Aló, T Dayaram, K Ferenczi, ... Cancer research 64 (12), 4137-4147, 2004 | 94 | 2004 |
| Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1 HY Winter, T Dayaram, SJ Marriott Journal of virology 81 (23), 13075-13081, 2007 | 11 | 2007 |
| Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage T Dayaram, FJ Lemoine, LA Donehower, SJ Marriott PLoS One 8 (2), e55989, 2013 | 23 | 2013 |
| Automated hypothesis generation based on mining scientific literature S Spangler, AD Wilkins, BJ Bachman, M Nagarajan, T Dayaram, P Haas, ... Proceedings of the 20th ACM SIGKDD international conference on Knowledge …, 2014 | 176 | 2014 |
| Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations HS Radomska, DS Bassères, R Zheng, P Zhang, T Dayaram, ... The Journal of experimental medicine 203 (2), 371-381, 2006 | 243 | 2006 |
| C/EBPα mutations in lung cancer DB Costa, T Dayaram, F D’Alo, BJ Wouters, DG Tenen, M Meyerson, ... Lung cancer 53 (2), 253-254, 2006 | 16 | 2006 |
| C/EBPβ is required for'emergency'granulopoiesis H Hirai, P Zhang, T Dayaram, CJ Hetherington, S Mizuno, J Imanishi, ... Nature immunology 7 (7), 732-739, 2006 | 484 | 2006 |
| Candida albicans infection D Tenen, H Hirai, P Zhang, T Dayaram, C Hetherington, S Mizuno, ... | | 2006 |
| Cell staining for sorting of hematopoietic stem cells (HSC) and myeloid progenitors and isolating RNA from sorted cells D Tenen, H Hirai, P Zhang, T Dayaram, C Hetherington, S Mizuno, ... | | 2006 |
| Distinctive and indispensable roles of PU. 1 in maintenance of hematopoietic stem cells and their differentiation H Iwasaki, C Somoza, H Shigematsu, EA Duprez, J Iwasaki-Arai, ... Blood 106 (5), 1590-1600, 2005 | 544 | 2005 |
| Effect of transforming viruses on molecular mechanisms associated with cancer T Dayaram, SJ Marriott Journal of cellular physiology 216 (2), 309-314, 2008 | 47 | 2008 |
| Effects of the HTLV-I Oncoprotein, Tax, on Cellular Response to UV-damage and the Damage Induced Phosphatase WIP1 T Dayaram Baylor College of Medicine. Program in Cell and Molecular Biology, 2011 | | 2011 |
| Effects of TP53 mutational status on gene expression patterns across 10 human cancer types N Parikh, S Hilsenbeck, CJ Creighton, T Dayaram, R Shuck, E Shinbrot, ... The Journal of pathology 232 (5), 522-533, 2014 | 100 | 2014 |
| EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib S Kobayashi, TJ Boggon, T Dayaram, PA Jänne, O Kocher, M Meyerson, ... New England Journal of Medicine 352 (8), 786-792, 2005 | 4801 | 2005 |
| Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα P Zhang, J Iwasaki-Arai, H Iwasaki, ML Fenyus, T Dayaram, BM Owens, ... Immunity 21 (6), 853-863, 2004 | 673 | 2004 |
| Frequency of PU. 1 mutations in acute myeloid leukemia BU Mueller, T Pabst, M Osato, N Asou, LM Johansen, T Dayaram, ... Blood 102 (10), 3850-3851, 2003 | 1 | 2003 |
| Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing DS Basseres, F D’Alò, BY Yeap, EC Löwenberg, DA Gonzalez, H Yasuda, ... Lung cancer 77 (1), 31-37, 2012 | 56 | 2012 |
| Gefitinib resistance caused by a secondary mutation of the epidermal growth factor receptor S Kobayashi, TJ Boggon, T Dayaram, PA Janne, O Kocher, M Meyerson, ... Cancer Research 65 (9 Supplement), 620-621, 2005 | | 2005 |
| Hepatocyte nuclear factor 3 beta is epigenetically silenced by promoter hypermethylation in lung cancer B Wouters, T Dayaram, D Basseres, D Tenen, B Halmos Cancer Research 64 (7 Supplement), 431-431, 2004 | | 2004 |
